EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
Articles of Association
POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I/II CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR PCV24
Form of Proxy for use at the 2025 Annual General Meeting to be held on Wednesday, June 10, 2026
NOTICE OF 2025 ANNUAL GENERAL MEETING
2025 AGM CIRCULAR
VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR TD5CP ADOLESCENT AND ADULT
Monthly Return of Equity Issuer on Movements in Securities
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RULES OF PROCEDURES
1
2
3
4
5
6
52
津公网安备12011602300399
